Clinical Research Services

Geneuity™, a subsidiary of Molecular Pathology Laboratory Network, Inc. (MPLN), offers advanced clinical research services focused on accurately assessing the safety and effectiveness of experimental therapeutics and new diagnostic assays.

Directed by Neil Quigley, PhD, Geneuity has broad capabilities in design, optimization and validation of advanced molecular diagnostic assays and offers sponsors and CROs the capacity to develop novel assays for use in clinical trials

As a leader in molecular diagnostics, assay development and data management, Geneuity performs testing as part of FDA-approved clinical trials for in vitro diagnostic device manufacturers directly and for pharmaceutical companies indirectly through clinical research organizations (CROs).

Geneuity also provides routine testing for chemistries, hematology, toxicology / drug screening, urinalysis and allergy.